Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc.

Join Action
Case Details
Ticker JSPR
Class Period 11/30/2023 - 07/03/2025
Lead Plaintiff Deadline 11/18/2025
Days Left to Seek Plaintiff
35

If you are a Jasper Therapeutics investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics for allegedly misleading investors about its manufacturing controls, clinical trials, and financial stability. After disclosing major product and trial issues on July 7, 2025, Jasper’s stock dropped over 55%.

If you purchased Jasper shares between November 30, 2023 and July 3, 2025, you may be eligible to recover your losses.
Lead Plaintiff Deadline: November 18, 2025

📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
💻 Or submit your information below to learn about your rights.

Join Action
Jasper Therapeutics, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771